1. Artificial Neural Network Model for Predicting Lung Cancer Survival
    Hansapani Rodrigo et al, 2017, JDAIP CrossRef
  2. Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial
    Suresh S. Ramalingam et al, 2017, Clinical Lung Cancer CrossRef
  3. Endobronchial Ultrasound (EBUS) for Staging Lung Cancer in the Elderly Population—Specific Procedural and Medication Issues
    Lindsey Taylor et al, 2018, Curr Geri Rep CrossRef
  4. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival
    Bridget A. Quinn et al, 2018, Brachytherapy CrossRef
  5. ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC
    Hongbo Zhao et al, 2018, Front. Pharmacol. CrossRef
  6. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT
    Zhiyuan Tang et al, 2018, J Mol Med CrossRef
  7. Lung cancer detected on coronary artery calcium scoring computed tomography: factors delaying diagnosis and predictors of survival
    Jin Young Kim et al, 2018, Acta Radiol CrossRef
  8. Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapy.
    Nikhil Sebastian et al, 2019, Radiother Oncol CrossRef
  9. Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel
    C J Langer et al, 2015, Br J Cancer CrossRef
  10. Prognostic value of a novel scoring system using inflammatory response biomarkers in non‐small cell lung cancer: A retrospective study
    Yan Wang et al, 2019, Thorac Cancer CrossRef
  11. “Age matters”—German claims data indicate disparities in lung cancer care between elderly and young patients
    Julia Walter et al, 2019, PLoS ONE CrossRef
  12. Early treatment with metformin induces resistance against tumor growth in adult rats
    Amanda B Trombini et al, 2015, Cancer Biology & Therapy CrossRef
  13. Prognostic Value of Tumor-to-Blood Standardized Uptake Ratio in Patients with Resectable Non-Small-Cell Lung Cancer
    Seunghyeon Shin et al, 2017, Nucl Med Mol Imaging CrossRef
  14. Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients
    Yu Yu et al, 2017 CrossRef
  15. Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults
    Hui Guo et al, 2017, PLoS ONE CrossRef
  16. Distinct Prognostic Factors in Patients with Stage I Non–Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions
    Fangqiu Fu et al, 2019, Journal of Thoracic Oncology CrossRef
  17. Prognostic Factors Associated with Lung Cancer Survival: A Population-Based Study in Southern Spain
    Isabel Linares et al, 2019, COR CrossRef
  18. Association of Time-Varying Rest-Activity Rhythm With Survival in Older Adults With Lung Cancer
    Lou-Ching Kuo et al, 2020, Cancer Nursing CrossRef
  19. Comparing the effectiveness of different EGFR‐TKIs in patients with EGFR mutant non–small‐cell lung cancer: A retrospective cohort study in Taiwan
    Yao‐Yu Hsieh et al, 2020, Int. J. Cancer CrossRef
  20. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer
    Qing Huang et al, 2020, Medicine CrossRef
  21. Outcomes of Surgically Treated Patients with Stage IIB Non-small Cell Lung Cancer, a Single Center Experience
    Muhammet Sayan et al, 2020, Indian J Surg CrossRef
  22. Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade
    Miriam Möller et al, 2020, Journal of Immunotherapy CrossRef
  23. Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial
    Jonas Kuon et al, 2020, Trials CrossRef
  24. Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
    Anqi Wang et al, 2020, Cancer Med CrossRef
  25. Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy
    Shingo Shimada et al, 2020, World J Surg Onc CrossRef
  26. Surgery in patients with small cell lung cancer: A period propensity score matching analysis of the Seer database, 2010‑2015
    Xiaojun Du et al, 2019, Oncol Lett CrossRef
  27. Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR)
    Kyoichi Okishio et al, 2020, ESMO Open CrossRef
  28. The impact of beta blockers on survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Michael S. Oh et al, 2020, Clinical Lung Cancer CrossRef
  29. circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway
    Yutang Huang et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
  30. Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
    Begoña Campos‐Balea et al, 2020, Thorac Cancer CrossRef
  31. Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer
    Jeong-Oh Kim et al, 2020, Cancers CrossRef
  32. Validation of the 8th lung cancer TNM classification and clinical staging system in a German cohort of surgically resected patients
    Samantha Taber et al, 2020 CrossRef
  33. Acid-suppressive agents and survival outcomes in patients with cancer: a systematic review and meta-analysis
    Hyun Jin Song et al, 2020, Int J Clin Oncol CrossRef
  34. Health Disparities in Environmental and Occupational Lung Disease
    Emily Brigham et al, 2020, Clinics in Chest Medicine CrossRef
  35. Exceptional Survival Among Kentucky Stage IV Non‐small Cell Lung Cancer Patients: Appalachian Versus Non‐Appalachian Populations
    Vira Pravosud et al, 2020, The Journal of Rural Health CrossRef
  36. Identification of Prognostic Genes and Pathways in Lung Adenocarcinoma Using a Bayesian Approach
    Yu Jiang et al, 2017, Cancer Inform CrossRef
  37. Comprehensive Perspective for Lung Cancer Characterisation Based on AI Solutions Using CT Images
    Tania Pereira et al, 2020, JCM CrossRef
  38. Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study
    Hee Sang Hwang et al, 2021, Cancer Res Treat CrossRef
  39. Lung Cancer Attributed Mortality Among 316,336 Early Stage Breast Cancer Cases Treated by Radiotherapy and/or Chemotherapy, 2000–2015: Evidence From the SEER Database
    Semaw Ferede Abera et al, 2021, Front. Oncol. CrossRef
  40. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
    Aisha Al-Dherasi et al, 2021, Cancer Cell Int CrossRef
  41. Factors associated with early lung cancer mortality: a systematic review
    Christos Chouaïd et al, 2021, Expert Review of Anticancer Therapy CrossRef
  42. Is time-to-treatment associated with higher mortality in Korean elderly lung cancer patients?
    Kyu-Tae Han et al, 2021, Health Policy CrossRef
  43. Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD)
    Aisha Al-Dherasi et al, 2021, Cancer Cell Int CrossRef
  44. Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer
    Prantesh Jain et al, 2021, Front. Oncol. CrossRef
  45. Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy
    Kea Turner et al, 2021, Radiotherapy and Oncology CrossRef
  46. Racial Differences in Survival Among Advanced-stage Non–small-Cell Lung Cancer Patients Who Received Immunotherapy: An Analysis of the US National Cancer Database (NCDB)
    Anjali Gupta et al, 2022 CrossRef
    Sertan BULUT et al, 2021 CrossRef
  48. Prognostic factors for treatment response and survival outcomes after first-line management of Stage 4 non-small cell lung cancer: A real-world Indian perspective
    Avneet Garg et al, 2022, Lung India CrossRef
  49. Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors
    Bee-Song Chang et al, 2022, JPM CrossRef
  50. Association of Personal Characteristics and Effectiveness of Immunotherapy in Late-Stage Non-Small Cell Lung Cancer: A Systematic Review
    Krishna Patel et al, 2022 CrossRef
  51. A nine-gene signature identification and prognostic risk prediction for patients with lung adenocarcinoma using novel machine learning approach
    Eskezeia Yihunie Dessie et al, 2022, Computers in Biology and Medicine CrossRef
  52. Prognostic Impact of EGFR Amplification and Visceral Pleural Invasion in Early Stage Pulmonary Squamous Cell Carcinomas Patients after Surgical Resection of Primary Tumor
    Luís Miguel Chinchilla-Tábora et al, 2022, Cancers CrossRef
  53. Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma
    Chih-Hsiung Su et al, 2022, Cancers CrossRef